RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...

RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

We offer private clients a complete range of financial services, expert advice and individually tailored investment solutions based around liquidity, longevity and legacy, all backed up by our Chief ...

We value superior capital strength. It gives us the flexibility to address ... As trusted partners we deliver the best of UBS in a personalized, relevant, on-time and seamless experience. Connectivity ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Algert Global LLC acquired a new stake in shares of Microsoft Co. (NASDAQ:MSFT – Free Report) in the third quarter, according ...

Triton International Limited (the "Company" or "Triton") today announced the pricing of an underwritten offering of 6,000,000 of the Company’s 7.625% Series F Cumulative Redeemable Perpetual ...

Blue Square Asset Management LLC lifted its position in shares of JPMorgan Chase & Co. (NYSE:JPM – Free Report) by 2.5% in ...

Broadridge Financial Solutions, Inc. ( NYSE: BR) Q2 2025 Earnings Conference Call January 31, 2025 8:30 AM ET Edings Thibault – Head of Investor Relations Tim Gokey – Chief Executive Officer Ashima ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of ...